TIC Stock Analysis: Acuren | NYSE
Specialty Business Services | NYSE, USA | Market Cap: 1.793m USD | 12M Return: -40.6% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 14.0M
Warnings
Tailwinds
No distinct edge detected
Seasonality 1.3 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
TIC Solutions, Inc. (formerly Acuren Corporation) is a North American provider of asset integrity services, offering testing, inspection, certification, and compliance (TICC) solutions to industrial clients. Its core capabilities span nondestructive testing (NDT) techniques-including radiography, ultrasonic testing, magnetic particle inspection, penetrant testing, and visual inspection-used to evaluate equipment condition without causing damage or operational disruption.
Beyond traditional NDT, the company provides rope access technician services (covering inspection, welding, insulation, coatings, rigging, and electrical work), engineering consulting in areas such as failure investigation, corrosion and welding engineering, fracture mechanics, and chemical analysis, as well as geospatial data collection and analytics supporting asset management and infrastructure planning. Its customer base spans chemicals, pipelines, refineries, power generation, oilsands, automotive, aerospace, mining, manufacturing, renewable energy, and pulp and paper. Founded in 1974, the company is headquartered in Hollywood, Florida, and adopted the TIC Solutions name in October 2025.
The asset integrity and industrial inspection sector typically benefits from regulatory safety mandates and the operational risk-management needs of asset-heavy industries, which often require recurring inspection cycles rather than one-time purchases. Geospatial and data-analytics offerings extend the traditional inspection model into software-enabled infrastructure planning, a growing segment within industrial services.
- Pipeline and refinery capex drives inspection revenue growth
- Regulatory compliance mandates boost recurring TICC service demand
- Industrial maintenance spending rises on aging energy infrastructure
| Net Income: -102.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA 0.52 > 1.0 |
| NWC/Revenue: 38.50% < 20% (prev 24.49%; Δ 14.01% < -1%) |
| CFO/TA 0.02 > 3% & CFO 100.9m > Net Income -102.9m |
| Net Debt (1.37b) to EBITDA (171.9m): 7.97 < 3 |
| Current Ratio: 3.06 > 1.5 & < 3 |
| Outstanding Shares: last quarter (157.6m) vs 12m ago 29.74% < -2% |
| Gross Margin: 29.54% > 18% (prev 24.21%; Δ 5.33% > 0.5%) |
| Asset Turnover: 54.79% > 50% (prev 50.33%; Δ 4.46% > 0%) |
| Interest Coverage Ratio: -0.36 > 6 (EBIT TTM -36.7m / Interest Expense TTM 100.6m) |
| A: 0.16 (Total Current Assets 1.02b - Total Current Liabilities 333.4m) / Total Assets 4.33b |
| B: -0.05 (Retained Earnings -235.7m / Total Assets 4.33b) |
| C: -0.01 (EBIT TTM -36.7m / Avg Total Assets 3.26b) |
| D: 0.97 (Book Value of Equity 2.13b / Total Liabilities 2.20b) |
| Altman-Z'' = 1.81 = BBB |
| DSRI: 1.02 (Receivables 344.2m/206.7m, Revenue 1.78b/1.10b) |
| GMI: 0.82 (GM 24.21% / 29.54%) |
| AQI: 0.95 (AQ_t 0.70 / AQ_t-1 0.73) |
| SGI: 1.63 (Revenue 1.78b / 1.10b) |
| TATA: -0.05 (NI -102.9m - CFO 100.9m) / TA 4.33b) |
| Beneish M = -2.75 (Cap -4..+1) = A |
As of July 14, 2026, the stock is trading at USD 7.12 with a total of 1,482,858 shares traded. Over the past week, the price has changed by -12.96%, over one month by -16.73%, over three months by -1.79% and over the past year by -40.57%.
Current recommended Stop Loss: 6.50 (which is 8.7% or 1.6 ATR below the current price).
Acuren has received a consensus analysts rating of 3.50. Therefore, it is recommended to hold TIC.
- StrongBuy: 0
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 11.8 | 65.6% |
P/E Forward = 26.3852
P/S = 1.0048
P/B = 0.8287
Revenue TTM = 1.78b USD
EBIT TTM = -36.7m USD
EBITDA TTM = 171.9m USD
Long Term Debt = 1.59b USD (from longTermDebt, last quarter)
Short Term Debt = 55.7m USD (from shortTermDebt, last quarter)
Debt = 1.80b USD (from shortLongTermDebtTotal, last quarter) + Leases 93.6m
Net Debt = 1.37b USD (calculated: Debt 1.80b - CCE 426.6m)
Enterprise Value = 3.16b USD (1.79b + Debt 1.80b - CCE 426.6m)
Interest Coverage Ratio = -0.36 (Ebit TTM -36.7m / Interest Expense TTM 100.6m)
EV/FCF = 233.2x (Enterprise Value 3.16b / FCF TTM 13.6m)
FCF Yield = 0.43% (FCF TTM 13.6m / Enterprise Value 3.16b)
FCF Margin = 0.76% (FCF TTM 13.6m / Revenue TTM 1.78b)
Net Margin = -5.77% (Net Income TTM -102.9m / Revenue TTM 1.78b)
Gross Margin = 29.54% ((Revenue TTM 1.78b - Cost of Revenue TTM 1.26b) / Revenue TTM)
Gross Margin QoQ = 24.85% (prev 35.19%)
Tobins Q-Ratio = 0.73 (Enterprise Value 3.16b / Total Assets 4.33b)
Interest Expense / Debt = 5.60% (Interest Expense 100.6m / Debt 1.80b)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -29.0m (EBIT -36.7m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 3.06 (Total Current Assets 1.02b / Total Current Liabilities 333.4m)
Debt / Equity = 0.84 (Debt 1.80b / totalStockholderEquity, last quarter 2.13b)
Debt / EBITDA = 7.97 (Net Debt 1.37b / EBITDA 171.9m)
Debt / FCF = 101.0 (Net Debt 1.37b / FCF TTM 13.6m)
Total Stockholder Equity = 1.86b (last 4 quarters mean from totalStockholderEquity)
RoA = -3.16% (Net Income -102.9m / Total Assets 4.33b)
RoE = -5.53% (Net Income TTM -102.9m / Total Stockholder Equity 1.86b)
RoCE = -1.07% (EBIT -36.7m / Capital Employed (Equity 1.86b + L.T.Debt 1.59b))
RoIC = -0.73% (negative operating profit) (NOPAT -29.0m / Invested Capital 3.97b)
WACC = 7.72% (E(1.79b)/V(3.59b) * Re(11.02%) + D(1.80b)/V(3.59b) * Rd(5.60%) * (1-Tc(0.21)))
Discount Rate = 11.02% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 65.93 | Cagr: 61.00%
[DCF] Terminal Value 75.44% ; FCFF base≈13.6m ; Y1≈13.6m ; Y5≈14.4m
[DCF] Fair Price = N/A (negative equity: EV 224.3m - Net Debt 1.37b = -1.15b; debt exceeds intrinsic value)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -2.03 | # QB: -1
Revenue Correlation: 91.46 | Revenue CAGR: 20.72% | SUE: N/A | # QB: 0
EPS current Quarter (2026-03-31): EPS=0.02 | Chg30d=N/A | Revisions=+25% | Analysts=2
EPS next Quarter (2026-06-30): EPS=0.12 | Chg30d=-8.59% | Revisions=-25% | Analysts=3
EPS current Year (2026-12-31): EPS=0.29 | Chg30d=-36.59% | Revisions=-25% | GrowthEPS=+232.5% | GrowthRev=+43.4%
EPS next Year (2027-12-31): EPS=0.50 | Chg30d=-9.44% | Revisions=-25% | GrowthEPS=+72.2% | GrowthRev=+4.4%
[Analyst] Revisions Ratio: -29% (up=1, down=3)